In contrast to IL-12 and IL-27, the role of IL-23 in cancer appears controversial.28 The exogenous and endogenous overexpression of IL-23 in the tumor microenvironment shows a converse function among previously published data.2 Several studies revealed that exogenous overexpression of IL-23 induced a potent anti-tumor response. The gene discussed is IL27; the disease is cancer.